Skip to content

ROBA PHARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ROBA PHARMA

BE 0712.710.765
NACE 32.500, Manufacture of medical and dental instruments and supplies
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€3,538
2024 · €254,508-€250,970
Equity
€311,875
2024 · €308,336+€3,538
Cash
€27,829
2024 · €44,619-€16,790
Balance sheet total
€352,134
2024 · €1.2m-€874,103

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€985,075

    down €985,075 (-95.5%), from €1.0m to €46,208

    of which Trade receivables: -€986,443

  • Current investments +€125,000

    up €125,000 (+83.3%), from €150,000 to €275,000

  • Cash -€16,790

    down €16,790 (-37.6%), from €44,619 to €27,829

    mainly Trade debts (-€691,316) and Tax, wage and social debts (-€176,805)

Equity and liabilities
  • Trade debts -€691,316

    down €691,316 (-100.0%), from €691,346 to €30

  • Tax, wage and social debts -€176,805

    down €176,805 (-81.6%), from €216,555 to €39,750

Income statement
  • Gross operating margin -€283,410

    down €283,410 (-88.2%), from €321,480 to €38,070

  • Taxes -€94,982

    down €94,982 (-97.6%), from €97,287 to €2,305

  • Financial income -€22,824

    down €22,824 (-73.8%), from €30,924 to €8,100

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €254,508
Gross operating margin -€283,410
Depreciation -€381
Other operating charges -€2
Other operating items -€39,288
Financial income -€22,824
Financial charges -€47
Taxes +€94,982
Result 2025 €3,538
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€110,867
Investment -€127,656
Financing €0
Cash 2024 €44,619
Net result for the year +€3,538
Depreciation +€381
Receivables within one year +€985,075
Deferred charges and accrued income -€487
Trade debts -€691,316
Tax, wage and social debts -€176,805
Other debts -€9,520
Investment in fixed assets (net) -€2,656
Current investments -€125,000
Cash 2025 €27,829
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,226,237 €352,134 -€874,103 -71.3%
Fixed assets 21/28 - €2,275 +€2,275
Tangible fixed assets 22/27 - €2,275 +€2,275
Furniture and vehicles 24 - €2,275 +€2,275
Current assets 29/58 €1,226,237 €349,859 -€876,378 -71.5%
Amounts receivable within one year 40/41 €1,031,283 €46,208 -€985,075 -95.5%
Trade receivables 40 €1,026,283 €39,840 -€986,443 -96.1%
Other amounts receivable 41 €5,000 €6,368 +€1,368 +27.4%
Current investments 50/53 €150,000 €275,000 +€125,000 +83.3%
Cash at bank and in hand 54/58 €44,619 €27,829 -€16,790 -37.6%
Deferred charges and accrued income 490/1 €335 €822 +€487 +145%
Total equity and liabilities 10/49 €1,226,237 €352,134 -€874,103 -71.3%
Equity 10/15 €308,336 €311,875 +€3,538 +1.1%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €289,736 €293,275 +€3,538 +1.2%
Distributable reserves 133 €289,736 €293,275 +€3,538 +1.2%
Amounts payable 17/49 €917,901 €40,260 -€877,641 -95.6%
Amounts payable within one year 42/48 €917,901 €40,260 -€877,641 -95.6%
Trade debts 44 €691,346 €30 -€691,316 -100.0%
Suppliers 440/4 €691,346 €30 -€691,316 -100.0%
Taxes, remuneration and social security 45 €216,555 €39,750 -€176,805 -81.6%
Taxes 450/3 €216,555 €39,750 -€176,805 -81.6%
Other amounts payable 47/48 €10,000 €480 -€9,520 -95.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 - €381 +€381
Other operating charges 640/8 €126 €128 +€2 +1.6%
Non-recurring operating charges 66A - €39,288 +€39,288
Gross operating margin 9900 €321,480 €38,070 -€283,410 -88.2%
Operating profit (loss) 9901 €321,354 -€1,728 -€323,081
Financial income 75/76B €30,924 €8,100 -€22,824 -73.8%
Recurring financial income 75 €30,924 €8,100 -€22,824 -73.8%
Financial charges 65/66B €483 €529 +€47 +9.6%
Recurring financial charges 65 €483 €529 +€47 +9.6%
Profit (loss) for the period before taxes 9903 €351,795 €5,843 -€345,952 -98.3%
Income taxes 67/77 €97,287 €2,305 -€94,982 -97.6%
Profit (loss) for the period 9904 €254,508 €3,538 -€250,970 -98.6%
Profit (loss) for the period to be appropriated 9905 €254,508 €3,538 -€250,970 -98.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.